Table 1.
Drug class/Compound | Organization | Highest development phase | Notes |
---|---|---|---|
β-Adrenergic blocker | |||
SYL040012 | Zeltia/Sylentis | PI/II | β2-adrenergic antagonist – siRNA |
Prostaglandin analogs | |||
AR-102; mopidamol | Aerie | PII | FP agonist |
BOL-303259-X; NCX-116; PF-03187207 | NicOx/Bausch and Lomb | PII | Nitric oxide donating PGF2α agonist; NicOx and Bausch and Lomb partner in 2010 |
Taprenepag isopropyl; PF-04217329 | Pfizer | PII | EP2 agonist |
Abbreviations: siRNA, small interfering RNA.